Abstract
Gemcitabine (Gem) is currently used as the first-line therapy for liver and pancreatic cancer but has limited efficacy in most cases. Dexamethasone (D......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
